# Biopôle

> Biopôle is a VC fund in Epalinges backing Biotechnology, Health Care and Medical. See 10 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Epalinges, Switzerland
- Total investments: 10
- Last investment: Nov 2025
- Lead investor: 90%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/biopole/
- X (Twitter): https://twitter.com/biopolelausanne
- Website: https://www.biopole.ch

Biopôle is a clinical work and research firm.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $112k–$112k |
| Grant | $65k–$99k |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 4 | 40% |
| Health Care | 3 | 30% |
| Medical | 2 | 20% |
| Therapeutics | 2 | 20% |
| Manufacturing | 2 | 20% |

18 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Grant | 5 | 50% |
| Seed | 3 | 30% |
| Corporate Round | 1 | 10% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Emovo Care | Emovo Care SA is an ISO 13485 certified medical device company developing accessible robotic devices to bring movement home for people with motor impairments. The first product is an active orthosis that enables hemiparetic stroke patients to move their hands at home and will be CE marked by 2022. The core technology behind the device was developedduring a PhD at EPFL, where the research received worldwide media attention for its novel brain-computer interfaces. | $111.6K | Seed | Nov 06, 2025 |  |
| Precise Health | Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to end the threat of antimicrobial resistance through an AI-powered technology. | $111.6K | Seed | Nov 06, 2025 |  |
| Novostia | Novostia is a privately held medical device company incorporated in 2017 in Microcity Neuchâtel, Switzerland, developing an innovative artificial heart valve, designed for patients of any age, including children. | $6.6M | Corporate Round | Sep 09, 2024 |  |
| Parithera | Precision oncology includes new ways of treating cancer such as targeted therapies and immunotherapies. These approaches are more specific and effective than current treatments. In the near future, they will considerably reduce worldwide cancer burden. As of today, only a fraction of the 18 million yearly diagnosed patients benefit from precisiononcology. To increase the number of beneficiaries, new diagnostic tools are needed to match the specific needs of precision oncology to define patients' eligibility and monitor treatment response. | $98.6K | Grant | Oct 05, 2023 |  |
| Limula | Limula provides a unique platform technology enabling scale out of cell therapy production. By bringing manufacturing closer to the patients, our solution will broaden access to these highly personalised treatments. Our patented solution is composed of an automation unit and single use kits, allowing healthcare providers to safely manufacture CGTin a decentralized manner. We support companies at all stages of the cell therapy life cycle, from R&D to routine production. | $98.6K | Grant | Oct 05, 2023 |  |
| Voltiris | Voltiris develops solar modules for greenhouses. The company uses spectral filtering technology to allow essential light for plant growth to pass through while converting unused light into renewable energy. This dual-use approach enables greenhouse owners to generate electricity without compromising crop yield, promoting sustainability and energyindependence. | $98.6K | Grant | Oct 05, 2023 |  |
| PeriVision | Perivision combines artificial intelligence, virtual reality, and the cloud to build the next generation of systems to understand visual function. The company's systems improve workflow efficiency in practices and hospitals and provide deeper clinical insight into eye diseases. |  | Seed | Jul 18, 2023 |  |
| Volumina Medical | Volumina is active in the field of tissue engineering and develops injectable 3D scaffolds for the reconstruction of volumes of soft tissues (fat, muscles, glandular tissues, supporting and connective tissues) that have been lost after tumor ablation, disease, trauma, or for purely esthetically purposes. | $90K | Grant | Feb 03, 2023 |  |
| Limula | Limula provides a unique platform technology enabling scale out of cell therapy production. By bringing manufacturing closer to the patients, our solution will broaden access to these highly personalised treatments. Our patented solution is composed of an automation unit and single use kits, allowing healthcare providers to safely manufacture CGTin a decentralized manner. We support companies at all stages of the cell therapy life cycle, from R&D to routine production. | $65.1K | Grant | Oct 11, 2022 |  |
| biped.ai | biped is the future of accessibility. A smart shoulder-worn harness that uses autonomous driving technology to guide blind and partially-sighted people with 3D sounds. Ideal complement to your white cane or guide dog. All-in-one. |  | Grant |  |  |

10 of 10 investments shown.

## Co-investors
- [DART Ventures](https://shizune.co/investors/profile/dart-17) — VC Fund, 1 deal together
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund, 1 deal together
- [SICTIC](https://shizune.co/investors/profile/sictic) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund
- [Business Finland](https://shizune.co/investors/profile/tekes) — VC Fund

### Similar country
- [SICTIC](https://shizune.co/investors/profile/sictic) — VC Fund
- [Zürcher Kantonal Bank](https://shizune.co/investors/profile/z%C3%BCrcher-kantonalbank) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund

## Featured in investor lists
- [Medical Device Investors in Switzerland](https://shizune.co/investors/medical-device-investors-switzerland)
- [Wellness VC Funds in Switzerland](https://shizune.co/investors/wellness-vc-funds-switzerland)

## FAQ

### What does Biopôle invest in?

Biopôle invests primarily in Biotechnology, Health Care and Medical startups, most often at Grant and Seed stage. Most of the 10 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Biopôle's check size?

Biopôle typically joins rounds of $112k–$112k at Seed and $65k–$99k at Grant. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Biopôle participates in.

### When did Biopôle last invest?

The most recent investment recorded for Biopôle closed in Nov 2025. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co